To assess the efficacy of negative pressure wound therapy (NPWT) in reducing surgical site infections (SSI) and improving wound healing, highlighting its significance in surgical practice.
Key Findings:
The 2022 Cochrane review indicated moderate-certainty evidence favoring NPWT for reducing SSIs in surgical contexts.
The SUNRRISE trial showed no influence of iNPWT on SSI rates after emergency laparotomy, highlighting the need for further investigation.
The SWHSI-2 trial found no benefit of NPWT in healing time for wounds healing by secondary intention, suggesting limitations in its application.
Interpretation:
Despite some evidence supporting NPWT, recent trials question its effectiveness and cost-efficiency, suggesting a need for further robust, context-specific studies to inform clinical practice.
Limitations:
Potential biases in included studies and funding sources may affect the reliability of findings, particularly regarding industry influence.
Variability in trial designs and interventions complicates the interpretation of results, necessitating careful consideration.
Conclusion:
While NPWT shows promise, recent evidence raises concerns about its effectiveness and cost, indicating that further research is necessary to clarify its role in surgical wound management, particularly in specific contexts.
